PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study.

导出 LinkOut

翻译打印收藏纠错

作者： Stephen,Daniels ^[1] ; Sonia,Caprio ^[2] ; Umesh,Chaudhari ^[3] ; Garen,Manvelian ^[3] ; Marie T,Baccara-Dinet ^[4] ; Aurelie,Brunet ^[4] ; Michel,Scemama ^[5] ; Virginie,Loizeau ^[5] ; Eric,Bruckert ^[6]

作者单位： University of Colorado School of Medicine, Aurora, CO, USA. Electronic address: Stephen.Daniels@childrenscolorado.org. ^[1] Yale Pediatric Endocrinology, New Haven, CT, USA. ^[2] Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA. ^[3] Sanofi, Montpellier, France. ^[4] Sanofi, Chilly-Mazarin, France. ^[5] Hôpital Pitié Salpêtrière, Paris, France; Institute of Cardiometabolism and Nutrition, Paris, France. ^[6]

关键词 Alirocumab Cardiovascular Heterozygous familial hypercholesterolemia PCSK9 inhibitor Pediatrics

主题词青少年(Adolescent);抗胆固醇血症药(Anticholesteremic Agents);儿童(Child);双盲法(Double-Blind Method);女(雌)性(Female);杂合子(Heterozygote);人类(Humans);高胆固醇血症Ⅱ型(Hyperlipoproteinemia Type II);男(雄)性(Male);中年人(Middle Aged);治疗结果(Treatment Outcome)

DOI 10.1016/j.jacl.2020.03.001

PMID 32331936

发布时间 2021-12-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of clinical lipidology

322-330.e5页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study.

Journal of clinical lipidology

相似文献

Journal of clinical lipidology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study.

Journal of clinical lipidology

相似文献

Journal of clinical lipidology

相关期刊

检索历史清除